Home gu-oncology-now-picks

gu-oncology-now-picks

Cabazitaxel, Circulating Tumor Cells Are Associated with Survival and Prognosis for Men Receiving Third-line Treatment for Metastatic Castration-resistant Prostate Cancer

Circulating Tumor Cells Are Associated with Survival and Prognosis for Men Receiving Third-line Treatment...

177Lu-PSMA-617 Improves Progression-free Survival and Patient-reported Outcomes Compared to Cabazitaxel for Men with Metastatic Castration-resistant Prostate Cancer

177Lu-PSMA-617 Improves Progression-free Survival and Patient-reported Outcomes Compared to Cabazitaxel for Men with Metastatic...

Relugolix Effectively Suppresses Testosterone Levels Regardless of Other Simultaneous Prostate Cancer Treatments

Relugolix Effectively Suppresses Testosterone Levels Regardless of Other Simultaneous Prostate Cancer Treatments

Enzalutamide

Enzalutamide Provides Similar Clinical Benefit for Men with Metastatic Hormone-sensitive Prostate Cancer Due to...

Load more
Subscribe to RSS